▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1342 by analyst upside · 2026-11-13
ODTX
Odyssey Therapeutics, Inc.
Healthcare · Market Cap $966M · P/E 0x
ANALYST PRICE TARGET
+72.5%
implied upside to consensus target
Current Price $20.1
Consensus Target $34.67
Bull Target $42.0
Bear Target $27.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
0
Sell
0
52-Week Low $15.1
52-Week High $29.05
YTD Return +22.4%
FUNDAMENTALS
Market Cap $966M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-6.33
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $15.1
52-Week High $29.05
Current Price $20.1
Bear Target $27.0
Bull Target $42.0
● Now $20.1 ● Target $34.67
TRADING DATA
Avg Volume 303K
YTD Return +22.4%
Analyst Count 6
Consensus Buy
Upside to Target +72.5%
Last Updated 2026-11-13

ANALYST SUMMARY

Odyssey Therapeutics, Inc. (ODTX) is currently trading at $20.1 with a Wall Street consensus price target of $34.67, implying potential upside of 72.5% over the next 12 months. 6 analysts currently cover ODTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $42.0, while the most cautious has a target of $27.0.

ODTX operates in the Healthcare sector with a market capitalisation of $966M. The stock is up 22.4% year-to-date and is currently trading near the lower end of its 52-week range of $15.1 – $29.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ODTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ● Initiated
Buy 2026-10-12 33% win rate (6 calls)
Raymond James ● Initiated
Outperform 2026-10-09 Building track record
HC Wainwright & Co. ● Initiated
Buy 2026-08-27 31% win rate (48 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-08-07 43% win rate (7 calls)
Oppenheimer reit
Outperform → Outperform 2026-06-18 14% win rate (7 calls)
Cantor Fitzgerald ● Initiated
Overweight 2026-06-02 40% win rate (10 calls)
TD Cowen ● Initiated
Buy 2026-06-02 Building track record
Wedbush ● Initiated
Outperform 2026-06-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
15/30
Consensus clarity
15/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →